Funder
National Institutes of Health
National Institute of Allergy and Infectious Diseases
Reference16 articles.
1. Safety and pharmacokinetics of LHF-535, a potential treatment for Lassa fever, in healthy adults;Amberg;Antimicrob. Agents Chemother.,2022
2. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa;Briese;PLoS Pathog.,2009
3. Lassa antiviral LHF-535 protects Guinea pigs from lethal challenge;Cashman;Sci. Rep.,2022
4. Sabia virus-like Mammarenavirus in patient with fatal hemorrhagic fever, Brazil, 2020;de Mello Malta;Emerg. Infect. Dis.,2020
5. Treatment of Argentine hemorrhagic fever;Enria;Antivir. Res.,2008